Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49450b7e72521eaf29af93c1dd261958 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52c8c0e4eed3e07993ce1c1c732bea14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae4f5093961e06aa12b732c3200c457b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8bec837a66bb49f57e2192d3d6ab92b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0278 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2010-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b23dd4d53aa290ff969dcceca9b4bdb5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_700a60d0b0a7772742b51ea864cc6700 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e71dcc5453d13fb1d7f65851e1017625 |
publicationDate |
2012-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8231877-B2 |
titleOfInvention |
Heterologous antibodies which bind human CD4 |
abstract |
The invention relates to transgenic non-human animals capable of producing high affinity human sequence antibodies. The invention is also directed to human sequence antibodies specific for human antigens , such as, human CD4. The invention also is directed to methods for producing human sequence antibodies. |
priorityDate |
1996-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |